Literature DB >> 26460996

Single-Isocenter Multiple-Target Stereotactic Radiosurgery: Risk of Compromised Coverage.

Justin Roper1, Vorakarn Chanyavanich2, Gregory Betzel2, Jeffrey Switchenko3, Anees Dhabaan2.   

Abstract

PURPOSE: To determine the dosimetric effects of rotational errors on target coverage using volumetric modulated arc therapy (VMAT) for multitarget stereotactic radiosurgery (SRS). METHODS AND MATERIALS: This retrospective study included 50 SRS cases, each with 2 intracranial planning target volumes (PTVs). Both PTVs were planned for simultaneous treatment to 21 Gy using a single-isocenter, noncoplanar VMAT SRS technique. Rotational errors of 0.5°, 1.0°, and 2.0° were simulated about all axes. The dose to 95% of the PTV (D95) and the volume covered by 95% of the prescribed dose (V95) were evaluated using multivariate analysis to determine how PTV coverage was related to PTV volume, PTV separation, and rotational error.
RESULTS: At 0.5° rotational error, D95 values and V95 coverage rates were ≥95% in all cases. For rotational errors of 1.0°, 7% of targets had D95 and V95 values <95%. Coverage worsened substantially when the rotational error increased to 2.0°: D95 and V95 values were >95% for only 63% of the targets. Multivariate analysis showed that PTV volume and distance to isocenter were strong predictors of target coverage.
CONCLUSIONS: The effects of rotational errors on target coverage were studied across a broad range of SRS cases. In general, the risk of compromised coverage increased with decreasing target volume, increasing rotational error and increasing distance between targets. Multivariate regression models from this study may be used to quantify the dosimetric effects of rotational errors on target coverage given patient-specific input parameters of PTV volume and distance to isocenter.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26460996      PMCID: PMC4610743          DOI: 10.1016/j.ijrobp.2015.07.2262

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Model-checking techniques based on cumulative residuals.

Authors:  D Y Lin; L J Wei; Z Ying
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Testing of the analytical anisotropic algorithm for photon dose calculation.

Authors:  Ann Van Esch; Laura Tillikainen; Jukka Pyykkonen; Mikko Tenhunen; Hannu Helminen; Sami Siljamäki; Jyrki Alakuijala; Marta Paiusco; Mauro Lori; Dominique P Huyskens
Journal:  Med Phys       Date:  2006-11       Impact factor: 4.071

3.  A logistic regression model for the decision to perform access surgery.

Authors:  W J Loesche; G Taylor; J Giordano; R Hutchinson; C F Rau; Y M Chen; M A Schork
Journal:  J Clin Periodontol       Date:  1997-03       Impact factor: 8.728

4.  The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets.

Authors:  Dante E Roa; Daniel C Schiffner; Juying Zhang; Salam N Dietrich; Jeffrey V Kuo; Jason Wong; Nilam S Ramsinghani; Muthana S A L Al-Ghazi
Journal:  Med Dosim       Date:  2012-02-24       Impact factor: 1.482

5.  Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery.

Authors:  Thierry Gevaert; Dirk Verellen; Benedikt Engels; Tom Depuydt; Karina Heuninckx; Koen Tournel; Michael Duchateau; Truus Reynders; Mark De Ridder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-09-22       Impact factor: 7.038

6.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

7.  Feasibility of single-isocenter volumetric modulated arc radiosurgery for treatment of multiple brain metastases.

Authors:  Grant M Clark; Richard A Popple; P Edward Young; John B Fiveash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

8.  Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery.

Authors:  Matthias Guckenberger; Johannes Roesch; Kurt Baier; Reinhart A Sweeney; Michael Flentje
Journal:  Radiat Oncol       Date:  2012-04-24       Impact factor: 3.481

9.  Six degrees of freedom CBCT-based positioning for intracranial targets treated with frameless stereotactic radiosurgery.

Authors:  Anees Dhabaan; Eduard Schreibmann; Arsalan Siddiqi; Eric Elder; Tim Fox; Tomi Ogunleye; Natia Esiashvili; Walter Curran; Ian Crocker; Hui-Kuo Shu
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

10.  Geometric and dosimetric uncertainties in intracranial stereotatctic treatments for multiple nonisocentric lesions.

Authors:  Brian Winey; Marc Bussiere
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

View more
  43 in total

1.  Towards frameless maskless SRS through real-time 6DoF robotic motion compensation.

Authors:  Andrew H Belcher; Xinmin Liu; Steven Chmura; Kamil Yenice; Rodney D Wiersma
Journal:  Phys Med Biol       Date:  2017-11-13       Impact factor: 3.609

Review 2.  Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues.

Authors:  Arjun Sahgal; Mark Ruschin; Lijun Ma; Wilko Verbakel; David Larson; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Evaluation of additional treatment margins for compensating rotational random errors in linac-based single-isocenter stereotactic radiotherapy for multiple brain metastases.

Authors:  Yasuhisa Yoshida; Maki Soyama; Rieko Azumi
Journal:  J Radiosurg SBRT       Date:  2022

4.  Is there a volume threshold of brain metastases for Linac-based stereotactic radiotherapy?

Authors:  Chieh-Wen Liu; Saeed Ahmed; Tara Gray; Tianjun Ma; Young-Bin Cho; Gennady Neyman; Samuel Chao; John Suh; Ping Xia
Journal:  J Radiosurg SBRT       Date:  2021

5.  Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems.

Authors:  Giorgio Hamid Raza; Luca Capone; Paolo Tini; Martina Giraffa; Piercarlo Gentile; Giuseppe Minniti
Journal:  Radiat Oncol       Date:  2022-07-01       Impact factor: 4.309

6.  Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.

Authors:  Hania A Al-Hallaq; Steven Chmura; Joseph K Salama; Kathryn A Winter; Clifford G Robinson; Thomas M Pisansky; Virginia Borges; Jessica R Lowenstein; Susan McNulty; James M Galvin; David S Followill; Robert D Timmerman; Julia R White; Ying Xiao; Martha M Matuszak
Journal:  Pract Radiat Oncol       Date:  2016-05-20

7.  Restricted single isocenter for multiple targets dynamic conformal arc (RSIMT DCA) technique for brain stereotactic radiosurgery (SRS) planning.

Authors:  Jenghwa Chang; A Gabriella Wernicke; Susan C Pannullo
Journal:  J Radiosurg SBRT       Date:  2018

8.  Operation and calibration of the novel PTW 1600SRS detector for the verification of single isocenter stereotactic radiosurgery treatments of multiple small brain metastases.

Authors:  Esther Decabooter; Ans Cc Swinnen; Michel C Öllers; Fabian Göpfert; Frank Verhaegen
Journal:  Br J Radiol       Date:  2021-06-11       Impact factor: 3.629

9.  Single isocenter SRS using CAVMAT offers improved robustness to commissioning and treatment delivery uncertainty compared to VMAT.

Authors:  Edward T Cullom; Yuqing Xia; Kai-Cheng Chuang; Zachary W Gude; Yana Zlateva; Justus D Adamson; William M Giles
Journal:  J Appl Clin Med Phys       Date:  2021-06-24       Impact factor: 2.102

10.  Radiobiological evaluation considering setup error on single-isocenter irradiation in stereotactic radiosurgery.

Authors:  Hisashi Nakano; Satoshi Tanabe; Ryuta Sasamoto; Takeshi Takizawa; Satoru Utsunomiya; Madoka Sakai; Toshimichi Nakano; Atsushi Ohta; Motoki Kaidu; Hiroyuki Ishikawa
Journal:  J Appl Clin Med Phys       Date:  2021-06-20       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.